社区获得的菌肺炎:2019年至2024年成人住院患者的病例对照研究
Paola Di Carlo1, Nicola Serra2, Teresa Maria Assunta Fasciana1
1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
社区获得的莱吉欧内拉肺炎与心力衰竭等并发症有关. 对于高风险患者来说,早期检测和用宏类或诺类药物治疗至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 临床微生物学 临床微生物学
背景情况:
- 肺炎菌 (L. pneumophila) 是社区获得性肺炎的常见原因,通常与环境来源有关.
- 高风险人群,包括50岁以上,免疫力低下或患有先前疾病的人,特别容易受到感染.
- 这项研究调查了与L. pneumophila社区获取相关的因素,在住院的肺炎成年患者中.
研究的目的:
- 为了确定与Legionella pneumophila社区获得性肺炎相关的临床和实验室因素.
- 了解伴随性疾病在L. pneumophila感染中的作用.
- 为早期发现和治疗L. pneumophila肺炎的治疗策略提供信息.
主要方法:
- 一项涉及140名住院肺炎成年患者的病例控制研究.
- 数据收集包括人口统计,临床,实验室和微生物信息.
- 在入院后48小时内,使用尿抗原测试和BioFire FilmArray肺炎面板来检测军团性肺炎.
主要成果:
- 伴随性疾病,特别是心力衰竭和吸烟,与L. pneumophila存在有显著的关联.
- 患有L. pneumophila肺炎的患者表现出较低的血,和血小板水平.
- 在L. pneumophila阳性患者中观察到高水平的LDH,CRP,AST和ALT.
- 列沃弗洛克萨是最常见的治疗方法.
结论:
- 早期发现L.pneumophila非常重要,特别是在CRP升高,低血症或心力衰竭的患者中.
- 及时使用宏化物和基诺治疗对于降低L. pneumophila感染患者的死亡率至关重要.
- 识别风险因素和特定的实验室标记有助于及时诊断和管理.
更多相关视频
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
09:12Applying Live Cell Imaging and Cryo-Electron Tomography to Resolve Spatiotemporal Features of the Legionella pneumophila Dot/Icm Secretion System
Published on: March 10, 2020
相关概念视频
What are Populations and Communities?
SI Units: 2019 Redefinition
A standard set of units has been defined...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
